We are live on ! Find out more
KCM

Kennondale Capital Management Portfolio holdings

AUM $139M
1-Year Est. Return 44.52%
This Fund
S&P 500
This Quarter Est. Return
+10.6%
1 Year Est. Return
+44.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$98M
AUM Growth
+$6.27M
Cap. Flow
+$221K
Cap. Flow %
0.23%
Top 10 Hldgs %
30.47%
Holding
83
New
2
Increased
1
Reduced
4
Closed
1

Sector Composition

Rank Sector Weight
1 Financials 25.99%
2 Industrials 15.9%
3 Energy 11.82%
4 Consumer Discretionary 9.18%
5 Healthcare 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
76
Biogen
BIIB
$30.7B
$347K 0.35%
2,760
KOP icon
77
Koppers
KOP
$969M
$306K 0.31%
9,512
CHTR icon
78
Charter Communications
CHTR
$18.2B
$303K 0.31%
741
SOLV icon
79
Solventum
SOLV
$14.1B
$292K 0.3%
3,845
HUN icon
80
Huntsman Corp
HUN
$1.77B
$290K 0.3%
27,810
ALDX icon
81
Aldeyra Therapeutics
ALDX
$93.5M
$217K 0.22%
56,729
-94,551
-63% -$244K
TRC icon
82
Tejon Ranch
TRC
$451M
$186K 0.19%
10,961
PCH
83
DELISTED
PotlatchDeltic
PCH
-4,557
Closed -$206K

Similar funds

Kennondale Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Kennondale Capital Management held 83 positions worth $98M, up 6.8% from $91.7M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q2 2025: portfolio turnover was 3.6%. Kennondale Capital Management opened 2 new positions and exited 1, leaving the 83-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 25% a quarter earlier, followed by Industrials and Energy.

  • Kennondale Capital Management's largest Q2 2025 buy was Alpha Metallurgical Resources: 6,676 shares worth $751K.
  • Kennondale Capital Management added most to Stoke Therapeutics in Q2 2025, an estimated $181K increase.
  • Kennondale Capital Management's biggest Q2 2025 reduction was Amylyx Pharmaceuticals, cutting an estimated $523K.
  • Kennondale Capital Management fully exited PotlatchDeltic in Q2 2025, selling an estimated $206K.
  • Kennondale Capital Management's ten largest holdings make up 30% of its $98M portfolio in Q2 2025.
  • Kennondale Capital Management opened 2 new positions and closed 1 in Q2 2025.
  • Kennondale Capital Management's portfolio value rose 6.8% quarter-over-quarter to $98M.

Based on Kennondale Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.